Sign in

Immuneering Corp

Income Statement - Immuneering Corp (IMRX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.06 0.06 0.05 0.03 0.02 0.01
Operating income -0.06 -0.06 -0.06 -0.05 -0.03 -0.02 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.06 -0.06 -0.05 -0.05 -0.03 -0.02 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00
Net income -0.06 -0.06 -0.05 -0.05 -0.03 -0.02 -0.01
Show Quarterly Income Statement

Income Statement - Immuneering Corp (IMRX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 0.00 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.02 0.01 0.02 0.01 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Operating income -0.02 -0.01 -0.02 -0.01 -0.02 -0.02 -0.02 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 -13.91 0.00 -1.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.17 -36.07 0.09 0.11 0.15 0.04 0.01
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 -0.07
Other current assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.18 0.04 0.09 0.11 0.15 0.04 0.01
Total non-current assets + 0.06 0.01 0.01 0.01 0.01 0.00 0.00
Total assets 0.23 0.05 0.10 0.12 0.17 0.04 0.01
Total current liabilities + 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.01 0.06 0.02
Total liabilities 0.01 0.01 0.01 0.01 0.01 0.06 0.02
Total stockholders' equity + 0.22 0.04 0.09 0.11 0.16 -0.02 -0.01
Common shares outstanding 44 30 28 26 26 14 14
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 156.69 0.17 0.23 0.03 0.04 0.04 0.05 0.06 0.07 0.09 0.10 0.11 0.09 0.11 0.12 0.13 0.14 0.15 0.15 0.05 0.03 0.04 0.00 0.00 0.01
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00
Other current assets 4.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 161.41 0.18 0.23 0.03 0.04 0.04 0.06 0.06 0.07 0.09 0.10 0.11 0.09 0.11 0.12 0.13 0.14 0.15 0.15 0.05 0.03 0.04 0.01
Total non-current assets + 53.40 0.06 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 -0.01
Total assets 214.81 0.23 0.24 0.04 0.05 0.05 0.07 0.08 0.09 0.10 0.11 0.12 0.11 0.12 0.13 0.14 0.15 0.17 0.16 0.05 0.03 0.04
Total current liabilities + 4.97 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.00 0.00 0.00
Total non-current liabilities + 3.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.06
Total liabilities 8.29 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.06
Total stockholders' equity + 206.52 0.22 0.23 0.03 0.04 0.04 0.06 0.07 0.08 0.09 0.10 0.12 0.10 0.11 0.12 0.13 0.14 0.16 0.16 0.05 0.03 -0.02 0.01
Common shares outstanding 44 44 40 36 36 31 30 30 29 29 29 29 26 26 26 26 26 26 18 24 14 14 14 14 14
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + -0.05 -0.05 -0.05 -0.04 -0.03 -0.01 0.00
Cash flow from investing + -0.09 0.03 0.01 0.04 -0.08 0.00 0.00
Cash flow from financing + 0.23 0.01 0.03 0.00 0.14 0.04 0.02
Change in cash 0.09 -0.02 -0.01 0.00 0.04 0.02 0.01
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00
Cash flow from investing + -0.06 -0.09 0.00 0.00 0.00 0.01 -0.01 0.00 0.02 0.00 -0.02 0.01 0.02 0.01 0.00 0.02 0.01 -0.02 -0.05 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.21 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.03 0.03 0.04 0.03 0.03 0.00
Change in cash -0.08 -0.10 0.20 -0.01 0.00 -0.01 -0.01 -0.01 0.01 -0.01 -0.04 0.03 0.00 0.00 -0.01 0.01 0.00 -0.03 0.06 0.02 0.02 0.03 0.02 0.02 0.00
5 days ago

Immuneering Corp (IMRX) - Shares Outstanding Diluted

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Change In Inventory

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Net Income

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Stock Based Compensation

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Cashflow From Financing

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Cashflow From Investment

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Capital Expenditures

1Y 2Y 5Y Max
10 days ago

Immuneering Corp (IMRX) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
10 days ago